We are live on ! Find out more
CCP

Corient Capital Partners Portfolio holdings

AUM $1.34B
1-Year Est. Return 12.46%
This Fund
S&P 500
This Quarter Est. Return
+6.62%
1 Year Est. Return
-12.46%
3 Year Est. Return
+39.22%
5 Year Est. Return
+66.79%
10 Year Est. Return
AUM
$1.17B
AUM Growth
+$168M
Cap. Flow
+$113M
Cap. Flow %
9.71%
Top 10 Hldgs %
29.13%
Holding
630
New
97
Increased
410
Reduced
90
Closed
12

Top Sells

Rank Stock Value
1
VIG icon
Vanguard Dividend Appreciation ETF
VIG
+$8.59M
2
TRI icon
Thomson Reuters
TRI
+$2.36M
3
V icon
Visa
V
+$1.12M
4
MA icon
Mastercard
MA
+$1.04M
5
AZN icon
AstraZeneca
AZN
+$1.03M

Sector Composition

Rank Sector Weight
1 Technology 21.93%
2 Financials 10.78%
3 Healthcare 9.84%
4 Consumer Discretionary 8.35%
5 Communication Services 6.5%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
IPG
226
DELISTED
Interpublic Group of Companies
IPG
$799K 0.07%
+27,369
New +$722K
TSN icon
227
Tyson Foods
TSN
$20.5B
$798K 0.07%
10,742
+1,691
+19% +$117K
DD icon
228
DuPont de Nemours
DD
$18.8B
$796K 0.07%
8,207
+150
+2% +$14.4K
NVS icon
229
Novartis
NVS
$292B
$791K 0.07%
9,252
+833
+10% +$74.8K
MCK icon
230
McKesson
MCK
$97.3B
$780K 0.07%
4,001
+217
+6% +$39.6K
SHW icon
231
Sherwin-Williams
SHW
$87.5B
$779K 0.07%
3,168
+249
+9% +$59.3K
ALC icon
232
Alcon
ALC
$34.6B
$771K 0.07%
10,988
+382
+4% +$27K
TPL icon
233
Texas Pacific Land
TPL
$27.4B
$768K 0.07%
+4,347
New +$541K
CSX icon
234
CSX Corp
CSX
$93.4B
$764K 0.07%
23,793
+2,391
+11% +$73K
EMR icon
235
Emerson Electric
EMR
$86.1B
$762K 0.07%
8,443
+734
+10% +$63.1K
SLB icon
236
SLB Ltd
SLB
$74.8B
$759K 0.07%
27,914
+2,062
+8% +$54.3K
ECL icon
237
Ecolab
ECL
$78.8B
$754K 0.06%
3,525
+207
+6% +$44K
BIIB icon
238
Biogen
BIIB
$30.5B
$753K 0.06%
2,690
+360
+15% +$97.1K
SPG icon
239
Simon Property Group
SPG
$73.5B
$745K 0.06%
6,554
+900
+16% +$93.9K
CTRA
240
DELISTED
Coterra Energy
CTRA
$743K 0.06%
39,525
+38
+0.1% +$700
UNM icon
241
Unum
UNM
$14.4B
$741K 0.06%
+26,618
New +$691K
PODD icon
242
Insulet
PODD
$11.6B
$740K 0.06%
2,838
+1,594
+128% +$427K
WAL icon
243
Western Alliance Bancorporation
WAL
$9.28B
$740K 0.06%
+7,837
New +$649K
VRTX icon
244
Vertex Pharmaceuticals
VRTX
$121B
$738K 0.06%
3,436
+142
+4% +$31.2K
KEYS icon
245
Keysight
KEYS
$58.2B
$721K 0.06%
5,025
+392
+8% +$55.6K
PHM icon
246
Pultegroup
PHM
$25B
$717K 0.06%
13,668
+87
+0.6% +$4.06K
NEM icon
247
Newmont
NEM
$103B
$715K 0.06%
11,869
+232
+2% +$13.9K
IWF icon
248
iShares Russell 1000 Growth ETF
IWF
$127B
$714K 0.06%
11,748
+216
+2% +$13.1K
ROP icon
249
Roper Technologies
ROP
$38.5B
$711K 0.06%
1,763
-19
-1% -$7.63K
PGR icon
250
Progressive
PGR
$122B
$705K 0.06%
7,376
-289
-4% -$26.3K

Similar funds

Corient Capital Partners's Q1 2021 Portfolio in Review

As of Q1 2021, Corient Capital Partners held 630 positions worth $1.17B, up 17% from $1B the previous quarter. Its ten largest holdings account for 29% of the portfolio.

Corient Capital Partners deployed $113M of net new capital in Q1 2021, opening 97 new positions and adding to 410 existing holdings. Its largest new stake was Cloudflare: 600,373 shares worth $42.2M.

By sector, the portfolio is most concentrated in Technology at 22% of assets, up from 20% a quarter earlier, followed by Financials and Healthcare.

On the sell side, the largest reduction was Vanguard Dividend Appreciation ETF, an estimated $8.59M trimmed.

  • Corient Capital Partners's largest Q1 2021 buy was Cloudflare: 600,373 shares worth $42.2M.
  • Corient Capital Partners added most to Vanguard FTSE Developed Markets ETF in Q1 2021, an estimated $11.3M increase.
  • Corient Capital Partners's biggest Q1 2021 reduction was Vanguard Dividend Appreciation ETF, cutting an estimated $8.59M.
  • Corient Capital Partners fully exited Thomson Reuters in Q1 2021, selling an estimated $2.36M.
  • Corient Capital Partners's ten largest holdings make up 29% of its $1.17B portfolio in Q1 2021.
  • Corient Capital Partners opened 97 new positions and closed 12 in Q1 2021.
  • Corient Capital Partners's portfolio value rose 17% quarter-over-quarter to $1.17B.

Based on Corient Capital Partners's 13F filing for Q1 2021, filed 17 May 2021.